Screening for antibodies in narcolepsy type 1 and type 2

Screening for antibodies in narcolepsy type 1 and type 2

Détails bibliographiques
Auteurs principaux:	Giannoccaro, M, Waters, P, Pizza, F, Liguori, R, Plazzi, G, Vincent, A
Format:	Conference item
Publié:	Wiley 2017

Documents similaires

Antibodies against hypocretin receptor 2 are rare in narcolepsy
par: Giannoccaro, M, et autres
Publié: (2016)

Human hypocretin receptor 2 antibodies are rare in idiopathic narcolepsy
par: Giannoccaro, M, et autres
Publié: (2016)

Reviewing the Clinical Implications of Treating Narcolepsy as an Autoimmune Disorder
par: Giannoccaro MP, et autres
Publié: (2021-05-01)

Pediatric Narcolepsy Type 1: A State-of-the-Art Review
par: Valentina Baldini, et autres
Publié: (2024-06-01)

Creativity in Narcolepsy Type 1: The Role of Dissociated REM Sleep Manifestations
par: D'Anselmo A, et autres
Publié: (2020-12-01)

Dream Generation and Recall in Daytime NREM Sleep of Patients With Narcolepsy Type 1
par: Carlo Cipolli, et autres
Publié: (2020-11-01)

Physical Activity and Sleep/Wake Behavior, Anthropometric, and Metabolic Profile in Pediatric Narcolepsy Type 1
par: Marco Filardi, et autres
Publié: (2018-08-01)

Hypothalamus and amygdala functional connectivity at rest in narcolepsy type 1
par: Daniela Ballotta, et autres
Publié: (2021-01-01)

Case Report: Burden of Illness in Narcolepsy Type 1: Hikikomori in a Teenage Girl
par: Marco Filardi, et autres
Publié: (2021-03-01)

Navigating narcolepsy: exploring coping strategies and their association with quality of life in patients with narcolepsy type 1
par: Giorgia Varallo, et autres
Publié: (2024-05-01)

Validation of the Russian version of Swiss Narcolepsy Scale for narcolepsy type 1 screening
par: A. O. Golovatyuk, et autres
Publié: (2024-08-01)

Auxological and endocrine findings in narcolepsy type 1: seventeen-year follow-up from a pediatric endocrinology center
par: Sara Casale, et autres
Publié: (2023-06-01)

Impact of COVID‐19 pandemic lockdown on narcolepsy type 1 management
par: Emanuela Postiglione, et autres
Publié: (2021-01-01)

Autism Spectrum Disorder and Narcolepsy: A Possible Connection That Deserves to Be Investigated
par: Annio Posar, et autres
Publié: (2020-04-01)

Narcolepsy type 1
par: Rajesh Swarnakar, et autres
Publié: (2019-01-01)

Grey zone between narcolepsy type 1 and type 2
par: Gustavo Bruniera Fernandes, et autres

Gut Microbiota in Patients with Type 1 Narcolepsy
par: Zhang R, et autres
Publié: (2021-11-01)

Neuronal antibodies in children with or without narcolepsy following H1N1-AS03 vaccination
par: Thebault, S, et autres
Publié: (2015)

Comparing symptom measurement tools in pediatric narcolepsy
par: Philippe Lehert, et autres
Publié: (2022-12-01)

Progress of autonomic disturbances in narcolepsy type 1
par: Ying Wang, et autres
Publié: (2023-03-01)

Serum N‑Glycan Profiling of Patients with Narcolepsy Type 1 Using LC-MS/MS
par: Akeem Sanni, et autres
Publié: (2024-07-01)

Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy cases.
par: Guo Luo, et autres
Publié: (2017-01-01)

Orgasmolepsy in Narcolepsy Type 1 Responsive to Pitolisant: A Case Report
par: Pellitteri G, et autres
Publié: (2020-12-01)

Rare Case of Late-Onset Narcolepsy Type 1
par: Petra Kovalská, et autres
Publié: (2020-11-01)

Protocols of a diagnostic study and a randomized controlled non-inferiority trial comparing televisits vs standard in-person outpatient visits for narcolepsy diagnosis and care: TElemedicine for NARcolepsy (TENAR)
par: Francesca Ingravallo, et autres
Publié: (2020-05-01)

Neuronal Antibodies in Children with or without Narcolepsy following H1N1-AS03 Vaccination.
par: Simon Thebault, et autres
Publié: (2015-01-01)

Can a Peer Support the Process of Self-Management in Narcolepsy? A Qualitative Narrative Analysis of a Narcoleptic Patient
par: Christian Franceschini, et autres
Publié: (2020-07-01)

Correction: Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy cases.
par: Guo Luo, et autres
Publié: (2019-01-01)

Narcolepsy Type 1: A Remitting Disease? An Unusual Case Report
par: Vellieux G, et autres
Publié: (2021-09-01)

Prostaglandin D2 Receptor DP1 Antibodies Predict Vaccine-induced and Spontaneous Narcolepsy Type 1: Large-scale Study of Antibody Profiling
par: Helle Sadam, et autres
Publié: (2018-03-01)

Rarely Observed Symptoms in Narcolepsy Type-1 Case: Hypersexuality
par: Remzi Emre Şahin, et autres
Publié: (2024-09-01)

Quickly diagnosed and treated prepubertal Type 1 narcolepsy case
par: Fikret Poyraz Çökmüş, et autres
Publié: (2018-04-01)

Narcolepsy Type 1: Should We Only Target Hypocretin Receptor 2?
par: Rolf Fronczek, et autres
Publié: (2023-09-01)

LC-MS/MS-Based Proteomics Approach for the Identification of Candidate Serum Biomarkers in Patients with Narcolepsy Type 1
par: Akeem Sanni, et autres
Publié: (2023-02-01)

Role of Brown Adipose Tissue in Adiposity Associated With Narcolepsy Type 1
par: Maaike E. Straat, et autres
Publié: (2020-04-01)

Is narcolepsy an antibody-mediated autoimmune disease
par: Thebault, S
Publié: (2012)

Muscle Pain Sensitivity and Prevalence of Temporomandibular Disorders in Patients with Narcolepsy with Cataplexy: A Controlled Cohort Study
par: Maria Lavinia Bartolucci, et autres
Publié: (2023-06-01)

Absence of specific autoantibodies in patients with narcolepsy type 1 as indicated by an unbiased random peptide-displayed phage screening
par: Thi-Tuyet Trinh Tran, et autres
Publié: (2024-01-01)

Type 1 Narcolepsy in Pregnancy: A Case Report and Review of Literature
par: Asnat Yuabov, et autres
Publié: (2024-04-01)

A study on the optimal length of actigraphic recording in narcolepsy type 1
par: Damien Leger, et autres
Publié: (2019-01-01)